AGC Biologics is set to expand its Cell Line Development Centre of Excellence through a partnership with ATUM for integrating ...

AGC Biologics is partnering with ATUM to integrate technology designed to increase yields and shorten the path to clinical trials.

The problem of cell type became clear to genome biologist Jason Buenrostro in 2013. He was studying a cell line derived from someone with cancer, trying to map out how the DNA was arranged in the ...

Researchers recently enhanced the titer of a cell line still in development to produce adenovirus viral vectors by 7.5-fold, and without the risk of also producing replication-competent adenoviruses ...

AGC Biologics is expanding its Cell Line Development Center of Excellence by partnering with ATUM to integrate the Leap-In ...

How would you summarize your study for a lay audience? Advanced biliary tract cancer (BTC) includes cholangiocarcinoma, gallbladder carcinoma, and ampullary carcinoma. BTC is a rare and aggressive ...